IRIDEX CORP (IRIX) Form 8-K — Sep 2, 2026
IRIDEX Corporation received a notice from Nasdaq's Listing Qualifications Department on August 27, 2026, confirming that its common stock traded below the $1.00 per share minimum bid price for the last 30 consecutive business days, placing it out of compliance with Nasdaq Listing Rule 5550(a)(2). The company has 180 calendar days, until February 23, 2027, to regain compliance by achieving a closing bid price of at least $1.00 for a minimum of ten consecutive business days.
Key figures
- Nasdaq rule
- 5550(a)(2)
- Cure period days
- 180
- Minimum bid price
- $1.00 per share
- Compliance deadline
- February 23, 2027
- Second compliance period days
- 180
- Days needed to regain compliance
- 10
- Consecutive business days below minimum
- 30
Price after filing
Close on the filing date to close N calendar days later (from $0.72). Historical, not a forecast.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.